Literature DB >> 11999463

Qualitative and quantitative detection of urinary human complement factor H-related protein (BTA stat and BTA TRAK) and fragments of cytokeratins 8, 18 (UBC rapid and UBC IRMA) as markers for transitional cell carcinoma of the bladder.

M Babjuk1, M Kostírová, K Mudra, S Pecher, H Smolová, L Pecen, Z Ibrahim, J Dvorácek, L Jarolím, J Novák, T Zima.   

Abstract

OBJECTIVE: To evaluate the role of BTA stat, BTA TRAK, UBC Rapid, UBC IRMA and voided urinary cytology in the detection of bladder transitional cell carcinoma (TCC).
METHODS: The study included 78 patients with TCC of the bladder (group A), 62 patients with a history of bladder TCC without tumor recurrence at the time of examination (B, control group), 20 patients with other malignancy of the urinary tract (C), 38 patients with non-malignant urinary tract diseases (D), 10 patients with urinary tract infection (E) and 10 healthy volunteers (F). Except in group F, voided urine was collected before cystoscopy or cystectomy.
RESULTS: The specificity and sensitivity in bladder cancer detection were 87.1 and 74.4%, respectively with BTA stat, 79.3 and 48.7%, respectively with UBC Rapid, 100 and 33.3%, respectively with cytology, 72.6 and 75.6%, respectively with BTA TRAK, 64.5 and 70.5%, respectively with UBC IRMA.
CONCLUSIONS: The BTA stat and BTATRAK tests are superior to UBC Rapid, UBC IRMA and urinary cytology in detection of bladder TCC. In daily practice however cytology remains the best adjunct to cystoscopy because of its high sensitivity in Tis and 100% specificity. Cystoscopy cannot be replaced by any of evaluated methods.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11999463     DOI: 10.1016/s0302-2838(01)00015-x

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  13 in total

Review 1.  Early bladder cancer: concept, diagnosis, and management.

Authors:  Hiroshi Kitamura; Taiji Tsukamoto
Journal:  Int J Clin Oncol       Date:  2006-02       Impact factor: 3.402

Review 2.  Current Use and Promise of Urinary Markers for Urothelial Cancer.

Authors:  William Tabayoyong; Ashish M Kamat
Journal:  Curr Urol Rep       Date:  2018-10-17       Impact factor: 3.092

3.  Urine cytology and adjunct markers for detection and surveillance of bladder cancer.

Authors:  Peggy S Sullivan; Jessica B Chan; Mary R Levin; Jianyu Rao
Journal:  Am J Transl Res       Date:  2010-07-25       Impact factor: 4.060

4.  Biomarkers for detection and surveillance of bladder cancer.

Authors:  Lorne I Budman; Wassim Kassouf; Jordan R Steinberg
Journal:  Can Urol Assoc J       Date:  2008-06       Impact factor: 1.862

Review 5.  Guidelines for development of diagnostic markers in bladder cancer.

Authors:  Peter J Goebell; Susan L Groshen; Bernd J Schmitz-Dräger
Journal:  World J Urol       Date:  2008-02-06       Impact factor: 4.226

6.  [Urine marker systems for diagnosis of urothelial cancer].

Authors:  S Tritschler; F Strittmatter; A Karl; C Stief
Journal:  Urologe A       Date:  2013-07       Impact factor: 0.639

7.  Urinary UBC Rapid and NMP22 Test for Bladder Cancer Surveillance in Comparison to Urinary Cytology: Results from a Prospective Single-Center Study.

Authors:  Renate Pichler; Gennadi Tulchiner; Josef Fritz; Georg Schaefer; Wolfgang Horninger; Isabel Heidegger
Journal:  Int J Med Sci       Date:  2017-07-19       Impact factor: 3.738

8.  Diagnostic accuracy of the UBC® Rapid Test for bladder cancer: A meta-analysis.

Authors:  Pei Lu; Jianchun Cui; Keliang Chen; Qiang Lu; Jiexiu Zhang; Jun Tao; Zhijian Han; Wei Zhang; Rijin Song; Min Gu
Journal:  Oncol Lett       Date:  2018-07-05       Impact factor: 2.967

9.  The current role of telomerase in the diagnosis of bladder cancer.

Authors:  Sara Bravaccini; Valentina Casadio; Dino Amadori; Daniele Calistri; Rosella Silvestrini
Journal:  Indian J Urol       Date:  2009-01

10.  A Systematic Review of the Diagnostic and Prognostic Value of Urinary Protein Biomarkers in Urothelial Bladder Cancer.

Authors:  Jamie J D'Costa; James C Goldsmith; Jayne S Wilson; Richard T Bryan; Douglas G Ward
Journal:  Bladder Cancer       Date:  2016-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.